Eur Respir J 2006; 27:884-888
Copyright ©ERS Journals Ltd 2006
Multiple inflammatory hits and the pathogenesis of severe airway disease
I. D. Pavord,
S. S. Birring,
M. Berry,
R. H. Green,
C. E. Brightling and
A. J. Wardlaw
Institute for Lung Health, Dept of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester, UK.
CORRESPONDENCE: I. D. Pavord, Institute for Lung Health, Dept of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Leicester, LE3 9QP, UK. Fax: 44 116 2367768. E-mail: ian.pavord{at}uhl-tr.nhs.uk
Keywords: Asthma, asthma mechanisms, chronic obstructive pulmonary disease
Received: November 2, 2005
Accepted February 25, 2006
 |
ABSTRACT
|
|---|
Refractory or difficult-to-control asthma is associated with some clinical and pathological features normally associated with chronic obstructive pulmonary disease (COPD), raising the possibility that there are similarities in their pathogenesis. It is suggested that the coexistence of two or more inflammatory stimuli to the airway (multiple hits) is a key factor leading to the development of more severe airway disease. Airway inflammation in response to chronic inflammatory conditions elsewhere may be a particularly important additional inflammatory stimulus. The "multiple hit" hypothesis for the origins of severe airway disease has important implications for treatment and prevention, since identification and removal of additional inflammatory stimuli may delay progression of the underlying airway disease.
One of the most important questions facing researchers with an interest in airway disease is: why do the clinical consequences of chronic airway inflammation vary so much between patients? Why do some patients with asthma have refractory or difficult-to-control disease? Why do only a minority of smokers develop clinically significant chronic obstructive pulmonary disease (COPD)? This article will first use these clinical examples to show that severe airway disease is associated with a number of shared clinical and pathological features. It will then be suggested that these common factors could develop in response to the coexistence of two or more inflammatory stimuli to the airway. Finally, the authors will speculate that the clinical consequences of multiple inflammatory "hits" may be ameliorated by removal of additional inflammatory stimuli.
|
COMMON CLINICAL AND PATHOLOGICAL FEATURES OF REFRACTORY ASTHMA AND COPD
|
|---|
Refractory asthma can be defined as asthma that cannot be controlled with inhaled corticosteroids 1, 2. Many patients with asthma have refractory symptoms because of poor treatment concordance or because of persistent symptoms caused by the presence of comorbid conditions such as rhinitis and hyperventilation syndrome 3. However, there remain an important number of patients who have genuinely severe, therapy-resistant disease. Refractory asthma has heterogeneous clinical features, though some of the most distinctive abnormalities are features normally associated with COPD including: persistent symptoms, recurrent exacerbations, the presence of fixed airflow obstruction, and a degree of resistance to the effects of inhaled, and sometimes systemic, corticosteroid therapy 1–5. The pathology of refractory asthma also has features in common with COPD. It differs from the mild eosinophilic large airway inflammation seen in mild asthma in that there is a more complex lower airway inflammatory response, with increased neutrophilic as well as eosinophilic airway inflammation 2, 5 and involvement of the distal airways 4, 5. As in COPD, the inflammatory response is associated with abnormal tissue remodelling and damage. Although in many other ways the pattern of airway inflammation and remodelling differs from that seen in COPD 6, there can be similarities in associated features, including the presence of radiological evidence of bronchiectasis and emphysema 7 and physiological evidence of fixed airflow obstruction 1, 8.
The common clinical and pathological features seen in refractory asthma and COPD raise the possibility that some of the factors involved in the development of severe clinical consequences of asthma might be similar to those that increase the susceptibility of a smoker to the development of COPD. The authors suggest that one factor is the coexistence of two or more inflammatory stimuli to the airway. They highlight this because, if correct, it raises the possibility that identification and modulation of additional inflammatory stimuli might reduce progression of the underlying disease.
|
COEXISTENCE OF TWO OR MORE LOWER AIRWAY INFLAMMATORY RESPONSES
|
|---|
The hypothesis that multiple inflammatory stimuli are important in the pathogenesis of refractory asthma and COPD is supported by the frequent observation that when this occurs, many of the common clinical and pathological features previously highlighted tend to occur. Examples include the observations that patients with asthma who smoke have worse symptoms and lung function, a more neutrophil-dominated lower airway response, physiological evidence of involvement of the small airways, an impaired response to corticosteroids, and a more rapid decline in lung function over time 9, 10. Smoking has also been shown to be an independent predictor of the development of COPD in patients with eosinophilic bronchitis 11, a common cause of chronic cough in middle age which is associated with eosinophilic airway inflammation but not the airway hyperresponsiveness or variable airflow obstruction characteristic of asthma. Occupational exposures may be an important additional chronic inflammatory stimulus in some: miners who smoke are more likely to develop COPD than non-exposed smokers 12 and there is evidence that other dusty occupations are associated with the development of COPD and more severe asthma 1, 13, 14. Endotoxin, inhaled at work or at home, has been associated with the development of fixed airflow obstruction and more severe asthma 15. Latent airway infection is another potential additional inflammatory stimuli: the presence of adenoviral E1A protein in airway epithelial cells has been associated with an abnormally amplified inflammatory response in the distal lung in patients with COPD 16, and both chronic Mycoplasma pneumoniae and Chlamydia pneumoniae infection have been implicated in the pathogenesis of refractory asthma 17. Chronic viral infection is a potential explanation for increased CD8+ cell numbers in the airway, a feature which has been associated with more severe COPD 18 and with decline in forced expiratory volume in one second (FEV1) in asthma 19. Finally, colonisation and perhaps infection of the airway with Aspergillus fumigatus causes a mixed and intense eosinophilic and neutrophilic lower airway inflammatory response, which is associated with extensive airway damage and fixed airflow obstruction in patients with allergic bronchopulmonary aspergillosis 20.
The general principle that the coexistence of multiple inflammatory stimuli produces a more severe inflammatory response might also apply to acute inflammatory stimuli. This mechanism might be particularly important in the development of exacerbations of asthma and COPD. Experimental examples include the amplification of the acute lower airway response to inhaled allergen seen in subjects with atopic asthma after exposure to pollution 21 or inhaled endotoxin 22 and after viral infection 23.
|
AIRWAY INFLAMMATION IN RESPONSE TO CHRONIC INFLAMMATION ELSEWHERE AS A POTENTIAL ADDITIONAL INFLAMMATORY HIT
|
|---|
Observational studies of patients with cough or COPD who have neither significant smoking histories nor features suggesting underlying asthma or eosinophilic bronchitis have consistently found a high incidence of chronic inflammatory conditions elsewhere 24–26 suggesting that airway inflammation and dysfunction might complicate the primary inflammatory process. The most striking associations are seen with chronic inflammatory conditions involving organs that are embryologically related to the lungs, such as inflammatory bowel disease 27, 28, chronic hepatitis C infection 29, autoimmune thyroid disease 24, 28, 30 and Helicobacter pylori-induced gastritis 31, but airway disease is also commonly seen in more generalised inflammatory disorders such as rheumatoid arthritis 26, 32.
The physiological, radiological and pathological features of the airway disease seen in association with chronic inflammatory disorders have not been extensively investigated. There are some features in common with the obliterative bronchiolitis seen in chronic rejection in lung transplant recipients or chronic graft versus host disease in bone marrow transplant recipients 24–26, and it is possible that the airway disease is due to a similar, albeit low-grade inflammatory response involving aberrant homing of alloreactive lymphocytes to the lung.
Could the airway response to chronic inflammatory diseases elsewhere act as an important inflammatory hit? There is increasing evidence that it does. Studies in Japan show that chronic hepatitis C infection is associated with a more rapid decline in FEV1 in smokers 29 and in patients with asthma 33. The coexistence of chronic hepatitis C infection and asthma has also been associated with more severe asthma, which is less bronchodilator and corticosteroid responsive 33, 34. H. pylori-induced chronic gastritis is another chronic inflammatory condition that might be particularly important in the pathogenesis of COPD and refractory asthma since it is common and treatable. There is some epidemiological support for the presence of a causal link between H. pylori infection and airway disease 31 and it has long been recognised that peptic ulceration is strongly and independently associated with the presence of COPD 35, 36. In a recent study of Nottinghamshire (UK) miners, the present authors found that a past history of peptic ulceration (documented by barium studies, endoscopy or at surgery) was present in >50% of miners with severe COPD but only in 3% of miners with no respiratory symptoms and normal spirometric values 37. After correction for potential confounding factors, such as smoking, a past history of peptic ulceration was associated with a 13.3% lower post-bronchodilator FEV1 % predicted and 5.1% lower FEV1/forced vital capacity %. Typically, peptic ulceration occurred 10–20 yrs before the onset of respiratory symptoms, suggesting that the natural history of the conditions is different and raising the possibility that it may be possible to delay or prevent the onset of symptoms and airway dysfunction in at-risk smokers.
|
HOW DO MULTIPLE INFLAMMATORY STIMULI RESULT IN MORE SEVERE AIRWAY DISEASE?
|
|---|
The effects of multiple inflammatory stimuli may be just additive. The net result of different inflammatory stimuli will then depend on: whether it is an acute or chronic inflammatory stimulus; variations in the host response to the stimuli; the extent to which the stimulus provoke an eosinophil- or neutrophil-dominated inflammatory response; and the site where the inflammatory response predominates (fig. 1
). Thus, the "multiple hit" hypothesis for the origin of severe airway disease provides a basis for the heterogeneity of clinical and pathological features seen in refractory asthma and COPD 1–4, 8, 38.
View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1— Likely pathological response and predominant site of the airway inflammatory response to different stimuli. The net result of multiple inflammatory stimuli will depend on variations in the host response to the stimuli, the extent to which the stimuli provoke an eosinophil- or neutrophil-dominated inflammatory response and the site where the inflammatory response predominates. For example, a smoking miner with chronic Helicobacter pylori infection would tend to develop a completely corticosteroid-resistant, neutrophil-predominant distal lung disease with extensive emphysema; in contrast, a smoking miner who develops eosinophilic airway inflammation in response to an occupational sensitiser, would have more mixed features. LMW: low molecular weight.
|
|
There is also the possibility that the inflammatory response to different inflammatory stimuli interact in a synergistic fashion. This could occur at an early stage in the evolution of these responses. For example, smoking increases the risk of sensitisation to a variety of occupational high- and low-molecular weight sensitisers 39, and exposure to smoke or endotoxin has been associated with an increased risk of viral and bacterial infection 9, 15 and perhaps an increased potential for chronic infection. Many of the inflammatory stimuli previously highlighted are associated with activation of the innate immune response with upregulation of homing pathways and activation of effector inflammatory cells, such as neutrophils and monocyte/macrophages. This could have a knock-on effect on coexisting acute and chronic immune responses, leading to amplification and extension of these inflammatory responses. Mediators associated with innate immune responses have been implicated in the induction of corticosteroid resistance 40, which, as well as being associated with resistance to the effects of exogenous corticosteroids, might be associated with a diminished response to the natural anti-inflammatory brake provided by endogenous corticosteroids resulting in further amplification of the lower airway response. It is noteworthy that patients with asthma who smoke 41 and patients with refractory asthma 42 have a reduced cutaneous vasoconstrictor response to topical corticosteroids supporting the presence of a degree of endogenous corticosteroid resistance. Tumour necrosis factor (TNF)-
is expressed in increased amounts in the airway and on peripheral blood mononuclear cells in patients with refractory asthma when compared with patients with mild and moderate asthma 43, 44, and blood markers of TNF- activity, including C-reactive protein and soluble TNF- receptors, are increased in patients with COPD, particularly when the disease is severe or associated with wasting 45, 46. Preliminary findings with anti-TNF- therapy suggest that this mediator might be particularly important in the maintenance of the increased airway responsiveness and bronchoconstriction seen in some patients with severe airway disease 43, 44.
It is also possible that the number and importance of different inflammatory hits may change as the airway disease evolves. Severe COPD is associated with the development of lymphoid follicles in the small airways, implying the presence of an adaptive immune response 18. This immune response could be due to chronic infection or the exposure of auto-antigens as a result of increasing tissue damage.
The extent to which the coexistence of more than one acute or chronic inflammatory stimulus produces additive or synergistic effects and the mechanisms of these interactions remains unclear; it is therefore an important area for further study. Any hypothesis needs to account for the contrary situation in which airway inflammatory stimuli appear to protect against lung immunological injury. For example, the granulomatous inflammatory diseases sarcoidosis and extrinsic allergic alveolitis are less common in smokers 47, 48. Whether the interaction between particular inflammatory stimuli produces distinctive and readily recognisable pathological changes is another important area for further study.
|
COULD IDENTIFICATION AND REMOVAL OF ADDITIONAL INFLAMMATORY HITS REDUCE THE SEVERITY OF AIRWAY DISEASES?
|
|---|
A particular attraction of the multiple hit hypothesis is that it raises the possibility that identification and modification of inflammatory hits to the airway might lead to improved long-term outcome. Experience with smoking cessation 8–10, 49, removal of occupational dust exposure 12–14, avoidance of endotoxin exposure 15 and anti-fungal treatment in allergic bronchopulmonary aspergillosis 20 suggests that this might be the case. Intriguingly, there is also evidence that treatment of chronic inflammation outside the lung reduces the severity of associated airway diseases. The accelerated decline in FEV1 seen in smokers and patients with asthma, and the impaired corticosteroid and bronchodilator responsiveness of asthma, improve following successful treatment of chronic hepatitis C infection with interferon 29, 34. Other opportunities to investigate the effects of modulation of airway inflammation in response to chronic inflammation elsewhere are limited by the difficulty in treating some of these conditions; there is also contradictory information on the extent to which there is a direct link between the intensity of inflammation in the primary site and the intensity of the associated airway inflammatory response 27–29, 34. However, an obvious opportunity for an interventional study is to investigate the effects of H. pylori eradication on the natural history of asthma and COPD.
|
CONCLUSION
|
|---|
The authors' hypothesis raises the possibility that two of the more difficult clinical problems faced by chest physicians, the development of refractory disease in some patients with asthma and the abnormal rate of decline in lung function seen in some smokers, are due to multiple additive inflammatory stimuli to the airway. There are parallels between the authors' views on the pathogenesis of severe airway disease and current views on the pathogenesis of atheroma, where the importance of multiple causal factors is increasingly acknowledged. Perhaps a similar approach to management, with the emphasis on identification and modulation of the multiple hits to the airway, might be associated with the sort of clinical benefits currently being seen in vascular medicine.
|
REFERENCES
|
|---|
- Proceedings of the ATS workshop on refractory asthma. Am J Respir Crit Care Med 2000;162:2341–2351.[Free Full Text]
- The ENFUMOSA study group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003;22:470–477.[Abstract/Free Full Text]
- Heaney LS, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet 2005;365:974–976.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505–1510.[Abstract]
- Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide concentration in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005;25:986–991.[Abstract/Free Full Text]
- Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418–424.[Abstract/Free Full Text]
- Paganin F, Seneterre E, Chanez P, et al. Computed tomography of the lung in asthma: influence of disease severity and aetiology. Am J Respir Crit Care Med 1996;153:110–114.[Abstract]
- Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269–280.[Free Full Text]
- Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 2005;5:57–63.[Medline]
[Order article via Infotrieve]
- Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194–2000.[Abstract/Free Full Text]
- Berry M, Shaw D, Siva R, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005;35:598–601.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Lewis S, Bennett J, Richards K, Britton J. A cross sectional study of the independent effect of occupation on lung function in British coal miners. Occup Environ Med 1996;53:125–128.[Abstract]
- Oxman AD, Muir DC, Shannon HS, Stock SR, Hnizdon E, Lange HJ. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Am Rev Respir Dis 1993;148:38–48.[ISI][Medline]
[Order article via Infotrieve]
- Beach JR, Dennis JH, Avery AJ, et al. An epidemiological investigation of asthma in welders. Am J Respir Crit Care Med 1996;154:1394–1400.[Abstract]
- Reed CE, Milton DK. Endotoxin-stimulated innate immunity: a contributing factor for asthma. J Allergy Clin Immunol 2001;108:157–166.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469–473.[Abstract/Free Full Text]
- Lemanski RJ. Is asthma an infectious disease? Chest 2003;123:385S–390S.[Abstract/Free Full Text]
- Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645–2653.[Abstract/Free Full Text]
- van Rensen ELJ, Sont JK, Evertse CE, et al. Bronchial CD8 cell infiltrate and lung function decline in asthma. Am J Respir Crit Care Med 2005;172:837–841.[Abstract/Free Full Text]
- Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952–957.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Tunnicliffe WS, Burge PS, Ayres JG. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet 1994;344:1733–1736.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Eldridge MW, Peden DB. Airway response to concomitant exposure with endotoxin and allergen in atopic asthmatics. J Toxicol Environ Health 2000;61:27–37.
- Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200–2208.[ISI][Medline]
[Order article via Infotrieve]
- Birring SS, Brightling CE, Symon FA, Barlow SG, Wardlaw AJ, Pavord ID. Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003;58:1066–1070.[Abstract/Free Full Text]
- Birring SS, Brightling CE, Bradding P, et al. Clinical, radiographical and induced sputum features of chronic obstructive disease in non-smokers. A descriptive study. Am J Respir Crit Care Med 2002;166:1078–1083.[Abstract/Free Full Text]
- Turton CW, Williams G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805–810.[Abstract]
- Camus PH, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000;15:5–10.[ISI][Medline]
[Order article via Infotrieve]
- Birring SS, Morgan AJ, Prudon B, et al. Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease. Thorax 2003;58:533–536.[Abstract/Free Full Text]
- Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic Hepatitis C virus infection. Chest 2003;123:596–599.[Abstract/Free Full Text]
- Birring SS, Patel RB, Parker D, et al. Airway function and markers of airway inflammation in patients with hypothyroidism. Thorax 2005;60:249–253.[Abstract/Free Full Text]
- Caselli M, Zaffoni E, Ruina M, et al. Helicobacter pylori and chronic bronchtitis. Scand J Gastroenterol 1999;34:828–830.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Hassan WU, Keaney NP, Holland CD, Kelly CA. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis 1994;53:511–514.[Abstract/Free Full Text]
- Kanazawa H, Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004;116:749–752.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Kanazawa H, Mamoto T, Hirata K, Yoshikawa J. Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection. Chest 2003;123:600–603.[Abstract/Free Full Text]
- Flint FJ, Warrack HJN. Acute peptic ulceration in chronic emphysema. Lancet 1958;ii:178–179.
- Kroeker EJ, Leon AS. The association of diffuse obstructive pulmonary emphysema and chronic gastroduodenal ulceration. Dis Chest 1962;42:413–421.
- Siva R, Berry M, Green R, Pavord ID. Peptic ulcer disease and COPD in Nottinghamshire miners (abstract). Am J Respir Crit Care Med 2004;169:A617
- Brightling CE, Monterio W, Ward R, et al. Sputum eosinophilia and the short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000;356:1480–1485.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Chan-Yeung M, Malo J-L. Occupational asthma. N Engl J Med 1995;333:107–112.[Free Full Text]
- Franchimont D, Martens H, Hagelstein MT, et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999;84:2834–2839.[Abstract/Free Full Text]
- Livingston E, Chaudhuri R, McMahon AD, et al. Cutaneous vasoconstrictor response to topical corticosteroids is impaired in smokers with asthma (abstract). Proceedings of the American Thoracic Society 2005;2:A624
- Brown PH, Teelucksingh S, Matusiewicz SP, et al. Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 1991;337:576–580.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Howarth PH, Babu KS, Arshad HS, et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005;60:1012–1018.[Abstract/Free Full Text]
- Berry MA, Hargadon B, Shelley M, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006;354:697–708.[Abstract/Free Full Text]
- Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23–28.[Abstract/Free Full Text]
- Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:1218–1224.[Abstract/Free Full Text]
- Newman LS, Rose CS, Bresntz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324–1330.[Abstract/Free Full Text]
- Carrillo T, Rodriguez de Castro F, Cuevas M, Diaz F, Cabrera P. Effect of cigarette smoking on the humoral immune response in pigeon fanciers. Allergy 1991;46:241–244.[ISI][Medline]
[Order article via Infotrieve]
- Chaudhuri R, Livingston E, McMahon AD, et al. Airway inflammation following smoking cessation in asthma (abstract). Thorax 2005;60:ii5
This article has been cited by other articles:
|
|
|
|
 
I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte
Pathological networking: a new approach to understanding COPD
Postgrad. Med. J.,
May 1, 2008;
84(991):
259 - 264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sethi, R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B. J. B. Grant, and T. F. Murphy
Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 15, 2007;
176(4):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte
Pathological networking: a new approach to understanding COPD
Thorax,
August 1, 2007;
62(8):
733 - 738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. D Pavord
Non-eosinophilic asthma and the innate immune response
Thorax,
March 1, 2007;
62(3):
193 - 194.
[Full Text]
[PDF]
|
|
|
TOP
ABSTRACT
COMMON CLINICAL AND PATHOLOGICAL...
